New depression treatment targets the immune system instead of the brain

A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system.

In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life. ...